CHANGES IN LIPOPROTEIN COMPOSITION IN HYPERTRIGLYCERIDEMIC PATIENTS TAKING CHOLESTEROL-FREE FISH OIL SUPPLEMENTS

被引:22
作者
INAGAKI, M
HARRIS, WS
机构
[1] UNIV KANSAS, MED CTR,DEPT MED,DIV CLIN PHARMACOL, LIPID & ARTERIOSCLEROSIS PREVENT CLIN, KANSAS CITY, KS 66103 USA
[2] UNIV KANSAS, MED CTR, DEPT ANESTHESIOL, KANSAS CITY, KS 66103 USA
[3] SHOWA UNIV, SCH MED, DEPT PHARMACOL, TOKYO 142, JAPAN
关键词
Cholesterol; Docosahexaenoic acid; Eicosapentaenoic acid; Fish oil; HDL; LDL; Lipoproteins; Triglycerides; VLDL;
D O I
10.1016/0021-9150(90)90045-K
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fish oils rich in n - 3 fatty acids (FAs) have been shown to markedly lower levels of very low density lipoproteins (VLDL), but not the low density lipoproteins (LDL) which are derived from VLDL. Changes in the size and chemical composition of lipoproteins may affect their metabolism. In order to examine the effects of n - 3 FAs on lipoprotein metabolism, 6 patients with hypertriglyceridemia were given 6 g n - 3 FAs/day. Plasma lipid and apoprotein (apo A-I, A-II, B, E, C-II, C-III) levels (mg/dl) were measured before and after 4 weeks of treatment. Changes in lipoprotein size were assessed by gel chromatography. n - 3 FAs lowered VLDL cholesterol (58 ± 35 to 40 ± 30, P < 0.01) and total triglyceride (410 ± 170 to 236 ± 114, P < 0.01). In spite of this, LDL cholesterol levels did not decrease, and apo B levels increased (98 ± 28 to 111 ± 27, P < 0.05). HDL cholesterol rose (31 ± 5 to 34 ± 7, P < 0.05). The lipid content of smaller VLDL particles was reduced by over 40%, but the protein content was largely unchanged. Large triglyceride-rich lipoprotein particles were reduced to a greater extent than were small particles. These changes in VLDL particle size and composition may enhance the synthesis of LDL in hypertriglyceridemic patients taking n - 3 FA supplements. © 1990.
引用
收藏
页码:237 / 246
页数:10
相关论文
共 28 条
[1]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[2]   THE EFFECT OF FEEDING FISH OILS, VEGETABLE-OILS AND CLOFIBRATE ON THE KETOGENESIS FROM LONG-CHAIN FATTY-ACIDS IN HEPATOCYTES [J].
BERGSETH, S ;
CHRISTIANSEN, EN ;
BREMER, J .
LIPIDS, 1986, 21 (08) :508-514
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
BRONZERT TJ, 1977, CLIN CHEM, V23, P2089
[5]  
BUCOLO G, 1973, CLIN CHEM, V19, P476
[6]  
CHAPMAN MJ, 1986, METHOD ENZYMOL, V128, P70
[7]   POLY-UNSATURATED FATTY-ACIDS, HYPERLIPIDEMIA, AND THROMBOSIS [J].
GOODNIGHT, SH ;
HARRIS, WS ;
CONNOR, WE ;
ILLINGWORTH, DR .
ARTERIOSCLEROSIS, 1982, 2 (02) :87-113
[8]  
GOTO Y, 1986, J CLIN BIOCHEM NUTR, V1, P73
[9]  
HARRIS WS, 1989, J LIPID RES, V30, P785
[10]   OMEGA-3 FATTY-ACIDS IN HYPERTRIGLYCERIDEMIC PATIENTS - TRIGLYCERIDES VS METHYL-ESTERS [J].
HARRIS, WS ;
ZUCKER, ML ;
DUJOVNE, CA .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1988, 48 (04) :992-997